Steroid hormone synthetic pathways in prostate cancer
While androgen deprivation therapy (ADT) remains the primary treatment for metastatic prostate cancer (PCa) since the seminal recognition of the disease as androgen-dependent by Huggins and Hodges in 1941, therapy is uniformly marked by progression to castration-resistant prostate cancer (CRPC) over...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
AME Publishing Company
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219921/ |